AUPR909001A0 - Methods related to an a4 nicotinic acetylcholine receptor subunit mutant - Google Patents

Methods related to an a4 nicotinic acetylcholine receptor subunit mutant

Info

Publication number
AUPR909001A0
AUPR909001A0 AUPR9090A AUPR909001A AUPR909001A0 AU PR909001 A0 AUPR909001 A0 AU PR909001A0 AU PR9090 A AUPR9090 A AU PR9090A AU PR909001 A AUPR909001 A AU PR909001A AU PR909001 A0 AUPR909001 A0 AU PR909001A0
Authority
AU
Australia
Prior art keywords
acetylcholine receptor
nicotinic acetylcholine
methods related
receptor subunit
subunit mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR9090A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Priority to AUPR9090A priority Critical patent/AUPR909001A0/en
Publication of AUPR909001A0 publication Critical patent/AUPR909001A0/en
Priority to AU2002342402A priority patent/AU2002342402A1/en
Priority to PCT/AU2002/001583 priority patent/WO2003045499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AUPR9090A 2001-11-26 2001-11-26 Methods related to an a4 nicotinic acetylcholine receptor subunit mutant Abandoned AUPR909001A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPR9090A AUPR909001A0 (en) 2001-11-26 2001-11-26 Methods related to an a4 nicotinic acetylcholine receptor subunit mutant
AU2002342402A AU2002342402A1 (en) 2001-11-26 2002-11-25 METHODS RELATED TO AN Alpha4 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT MUTANT
PCT/AU2002/001583 WO2003045499A1 (en) 2001-11-26 2002-11-25 METHODS RELATED TO AN α4 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT MUTANT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR9090A AUPR909001A0 (en) 2001-11-26 2001-11-26 Methods related to an a4 nicotinic acetylcholine receptor subunit mutant

Publications (1)

Publication Number Publication Date
AUPR909001A0 true AUPR909001A0 (en) 2001-12-20

Family

ID=3832900

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR9090A Abandoned AUPR909001A0 (en) 2001-11-26 2001-11-26 Methods related to an a4 nicotinic acetylcholine receptor subunit mutant

Country Status (2)

Country Link
AU (1) AUPR909001A0 (en)
WO (1) WO2003045499A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6252132B1 (en) * 1998-11-02 2001-06-26 Institut Pasteur Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor

Also Published As

Publication number Publication date
WO2003045499A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2003265128A1 (en) Positive allosteric modulators of the nicotinic acetylcholine receptor
AU2003212296A1 (en) Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
AU2001228665A1 (en) Toll-like receptor
AU2002314433A1 (en) Ephrin-tie receptor materials and methods
AU2001273032A1 (en) Cytokine receptor zcytor17
AU2003285540A1 (en) Antibody for the thyrotropin receptor and uses thereof
AU2001278626A1 (en) Tetrahydropyran derivatives as nk-1 receptor antagonists
AU2001257449A1 (en) Imaging of nicotinic acetylcholine receptor subtypes
AU2003258126A1 (en) Transitional support for physically challenged persons
AU2001249573A1 (en) Chemokine receptor antagonists
AU2002218919A1 (en) Compositions and methods for regulating receptor clustering
AUPR909001A0 (en) Methods related to an a4 nicotinic acetylcholine receptor subunit mutant
AU2002335093A1 (en) Nr3b nmda receptor subunit compositions and related methods
AUPQ563400A0 (en) Novel receptor
AU2003287344A1 (en) Cantilever supported height adjustable headrest
AU2001223882A1 (en) Receptor
AU2002342402A1 (en) METHODS RELATED TO AN Alpha4 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT MUTANT
AU5647501A (en) Crystallography methods
AU2003254016A1 (en) Methods and compositions relating to chimeric nicotinic receptor subunits
AU2002307903A1 (en) G-protein coupled receptor
AU2001272417A1 (en) G-protein coupled receptor org3.
AU2001255472A1 (en) Novel g protein-coupled receptor con-218
AU2003281525A1 (en) Serotonin receptor
AU2002303093A1 (en) Mycobacterial vaccines
AU2003242244A1 (en) Chemokine receptor antagonist